1. Home
  2. UMBF vs TECH Comparison

UMBF vs TECH Comparison

Compare UMBF & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UMBF
  • TECH
  • Stock Information
  • Founded
  • UMBF 1913
  • TECH 1976
  • Country
  • UMBF United States
  • TECH United States
  • Employees
  • UMBF N/A
  • TECH N/A
  • Industry
  • UMBF Major Banks
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • UMBF Finance
  • TECH Health Care
  • Exchange
  • UMBF Nasdaq
  • TECH Nasdaq
  • Market Cap
  • UMBF 8.2B
  • TECH 8.9B
  • IPO Year
  • UMBF N/A
  • TECH 1989
  • Fundamental
  • Price
  • UMBF $109.56
  • TECH $61.49
  • Analyst Decision
  • UMBF Buy
  • TECH Buy
  • Analyst Count
  • UMBF 11
  • TECH 13
  • Target Price
  • UMBF $136.27
  • TECH $71.50
  • AVG Volume (30 Days)
  • UMBF 508.2K
  • TECH 2.0M
  • Earning Date
  • UMBF 10-28-2025
  • TECH 11-05-2025
  • Dividend Yield
  • UMBF 1.57%
  • TECH 0.52%
  • EPS Growth
  • UMBF 10.98
  • TECH N/A
  • EPS
  • UMBF 8.89
  • TECH 0.49
  • Revenue
  • UMBF $2,217,071,000.00
  • TECH $1,216,732,000.00
  • Revenue This Year
  • UMBF $68.75
  • TECH $3.64
  • Revenue Next Year
  • UMBF $7.86
  • TECH $7.59
  • P/E Ratio
  • UMBF $12.34
  • TECH $126.15
  • Revenue Growth
  • UMBF 45.52
  • TECH 3.85
  • 52 Week Low
  • UMBF $82.00
  • TECH $46.01
  • 52 Week High
  • UMBF $129.94
  • TECH $79.28
  • Technical
  • Relative Strength Index (RSI)
  • UMBF 45.05
  • TECH 54.24
  • Support Level
  • UMBF $109.11
  • TECH $56.53
  • Resistance Level
  • UMBF $108.47
  • TECH $62.67
  • Average True Range (ATR)
  • UMBF 2.64
  • TECH 2.34
  • MACD
  • UMBF 0.37
  • TECH -0.57
  • Stochastic Oscillator
  • UMBF 53.06
  • TECH 57.01

About UMBF UMB Financial Corporation

UMB Financial Corp, or UMBF, is a financial services holding company offering a suite of banking services and asset servicing to its customers in the United States and around the world. Its client base includes commercial, institutional, and personal customers. Along with its subsidiaries, the company operates in the following business segments: Commercial Banking, Institutional Banking, and Personal Banking. A majority of its revenue is generated from the Commercial Banking segment, which serves the commercial banking and treasury management needs of small to middle-market businesses through various products and services such as commercial loans, commercial real estate financing, commercial credit cards, letters of credit, loan syndication services, consultative services, and others.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: